Women’s History Month Spotlight: Dr. Carolyn Runowicz.✨ A nationally recognized leader in gynecologic oncology and first woman president of @SGO_org, Dr. Runowicz helped shape the future of women’s cancer care. Read her story: ow.ly/8iYP50YzOAf #WomensHistoryMonth #GynOnc

@ShannonWestin A W E S O M E lecture! #brasi #latam #GynOnc

Introducing #SurgicalSpotlight 🔥 🎥 Discover the 1st episode of this new #IJGC series with Reitan Ribeir@o @reitanribeiro, featuring surgical insights, expert discussion, and practical learning for the #gynonc community. bit.ly/3NPoQV9V0@x @pedroramirez@MD @HsuFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

On to the next chapter. I’m excited to start my gynecologic oncology fellowship this July—a long-awaited dream that’s now closer than ever. Grateful for the journey, and ready for what’s ahead. #match2026 #fellowship #gynonc #MedX

Calling all ENYGO members! 👋 Apply for the ENYGO Short Clinical Visit at Vall d’Hebron University Hosptial in Barcelona 🇪🇸 by March 31! It’s a great opportunity to learn at an ESGO-accredited centre. enygo.esgo.org/discover/short…jRjb #gyn8L4v

🚨New podcast episode out now 🎙️ Can ctDNA help us better personalize PARPi maintenance in ovarian cancer? Listen now for a timely discussion on the future of biomarker-driven treatment in ovarian cancer. #GynOnc #OvarianCancer #ctDNA #PARPi #PrecisionOncology Listen heretinyurl.com/yc3ksk7zIy

Ah yes, my favorite insurance denial for surgery. Robotic hyst/BSO, uterus weighs 325g. Preauth for 58571, bill for 58573, bill rejected bc I didn’t auth the correct code. Can’t preauth both codes. Can’t weigh the uterus until it’s removed. #gynonc #CPT #hyst #insuranceisascam

Meet new ESGO Council Member Michael Seckl 🤝 We caught up with him at the Congress in Copenhagen to ask what his top interests related to #gynonc are �uu

📢 Exciting news in #GynOnc! 🇯🇵 Risovalisib (PI3Kα inhibitor) is now approved in Japan for PIK3CA-mt Ovarian Clear Cell Carcinoma. While it's a vital new #PrecisionMedicine option, management of its unique side effects will be essential! #OvarianCanckk.haihepharma.com/news/news_2026…cXk

ربع مريضات سرطان عنق الرحم المرحلة IIIC1 عندهن انتشار خفي للغدد حول الأبهر — وPET/CT لا يراه دراسة PAROLA تسأل السؤال الأهم: هل الاستئصال الجراحي قبل الإشعاع يُنقذ هؤلاء؟ 510 مريضة | 18 مركزاً دولياً | النتائج 2030 قد تُعيد رسم خارطة علاج اورام عنق الرحم بالكامل #GynOnc

Don’t miss another chance to learn from Ane Gerde Zahl Eriksson 🇳🇴! At our April 9 webinar, she’ll discusss techniques for advanced #gynonc procedures with the robotic approach with our group of expert panelists. Sign up on the ESGO eAcademyeacademy.esgo.orgC #MeettheSurgeon

It was a privilege to participate in #ESGO2026 alongside colleagues dedicated to advancing gynecologic oncology. To access the research we shared in Copenhagen, visit the Lilly Oncology congress website: e.lilly/4r7h1YL #GYNOnc

🔎 How can social ecological model (SEM) frameworks aid cervical cancer prevention? 🩺 A study from a team of researchers in Brazil applied the framework to assess key facilitators and barriers to cervical cancer prevention. ➡️ Learn morebuff.ly/GLnYk1c1U #gynonsa

📋 Less than two-thirds of older adult patients with a recently diagnosed gynecologic malignancy had a visit scheduled with a gynecologic oncologist, according to a recent study investigating access disparities. ➡️ Learn more:buff.ly/xGhOJ2Io #gynonc #oncologynursingK

Platinum-resistant ovarian cancer holds a poor prognosis and is often treated with single-agent chemotherapy. A preprint aims to determine a recommended phase 2 dose (RP2D) of the combination of paclitaxel and lapatinib. 👇 Learn more. #GynOnc #CancerResearch #Oncology #MedEd3